Skip to main content
Livermore
Livermore
ZHEN

LivaNova PLC

LIVN
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001639691

In the last 90 days, LivaNova PLC insiders filed 0 open-market purchases and 4 sales; 303 institutions reported holding it in 13F filings for Q2 2026, worth $4.88B in total; no superinvestor holds it.

Holders of 5% or more of LIVN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of LivaNova PLC, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of LIVN
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A12.70%6.92M shares–Jul 18, 20251 filingJul 18, 2025SEC
Primecap Management Co13G/A8.76%4.75M shares–Feb 13, 20251 filingFeb 13, 2025SEC
Integrated Core Strategies (US) LLC13G/A5.40%2.97M shares+1.60 ppfrom 3.80%May 13, 20252 filingsNov 6, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on LivaNova PLC, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on LIVN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 6, 20254:19 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A5.40%2.97M shares+1.60 ppfrom 3.80%Sep 30, 2025SEC
Jul 18, 20252:15 PM ETBlackRock, Inc.13G/A12.70%6.92M shares–Jun 30, 2025SEC
May 13, 20254:00 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A3.80%2.07M shares–Below 5%Mar 31, 2025SEC
Feb 13, 20256:33 PM ETPrimecap Management Co13G/A8.76%4.75M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell LivaNova PLC shares.

No Form 144 notices for LivaNova PLC are on file.